NeuCyber, a Beijing-based brain chip company, has revealed that its Beinao-2 product, an invasive Brain-Computer Interface (BCI) with flexible electrodes for full brain implantation, is approximately three years behind Elon Musk’s Neuralink in technological advancement. While Beinao-2 is currently undergoing large-scale animal implantation, Neuralink boasts a significant technical edge with its surgical robot capable of inserting hundreds of electrodes into the brain within minutes for its invasive N1 chip.
This comparison underscores the fierce competition in the development of BCIs, signaling a race towards achieving higher precision and efficiency in brain-machine interfaces. The ability to seamlessly integrate with the brain has significant implications for medical research, neurological treatments, and potentially even human augmentation technologies in the future.
As NeuCyber strives to catch up with Neuralink’s pioneering work in BCI technology, the industry is witnessing a surge of innovation and investment in unlocking the mysteries of the human brain, paving the way for groundbreaking advancements in neuroscience and cognitive computing.
Source: Tech-Economic Times